News

PMA Insights: Week 23

19/05/2021

Author:

Amy Rudd, ACIM
About the Author

Article Tags

Biosimilars Funding HTA Oncology PMA Trends

Share this article

Related articles

Poster
10.06.2026
A comparison of conflict-of-interest (CoI) managem...

Expert contributions are critical to health technology assessment (HTA), particularly in rare diseas...

Read more
Insider Insights
09.06.2026
Spain HTA reform 2026: Will Your Evidence Measure ...

Spain has published Royal Decree 415/2026[1], setting out a new national framework for health techno...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch